作者
Steve PH Alexander, Richard E Roberts, Brad RS Broughton, Christopher G Sobey, Christopher H George, S Clare Stanford, Giuseppe Cirino, James R Docherty, Mark A Giembycz, Daniel Hoyer, Paul A Insel, Angelo A Izzo, Yong Ji, David J MacEwan, Jonathan Mangum, Sue Wonnacott, Amrita Ahluwalia
发表日期
2018/2
期刊
British journal of pharmacology
卷号
175
期号
3
页码范围
407
出版商
Wiley-Blackwell
简介
Reproducibility is a current concern for everyone involved in the conduct and publication of biomedical research. Recent attempts testing reproducibility, particularly the reproducibility project in cancer biology published in elife (https://elifesciences. org/collections/9b1e83d1/reproducibility-project-cancer-biology), have exposed major difficulties in repeating published preclinical experimental work. It is thought that some of these difficulties relate to uncertainty about the provenance of tools, lack of clarity in methodology and use of inappropriate approaches for analysis; the latter particularly related to untoward manipulation of images. In the past, some of these so-called untoward practices were considered the ‘norm’; however, today, the landscape is different. The expectations, not only of the readers of the published scientific word but also of the publishers and funders of research, have changed. This collective group …
引用总数